Production of quality bioanalytical data is an essential consideration in developing new therapies.
A4P ensure by effective study management, provider oversight and project consultancy services that these data are delivered on time, on budget and in compliance.
Marcia Toguchi has 11 years' experience in the pharmaceutical industry with background within drug development.
Marcia is a qualified dentist and has a PhD in Oral Biology.
Before joining A4P, she has worked at Astex Pharmaceuticals as a Clinical Biomarker Lead in various oncology clinical trials. Prior to Astex, she worked at Celgene as a scientist.
Jen is a Highly engaged Project Operations Manager with significant Central Lab, Pharmaceutical Development and Companion Diagnostics experience.
Passionate about utilizing Science and Data to advance Precision Medicine and transform the future of care.
Having a passion for the clinical trial industry I possess a diversified work experience.
I started as Clinical Study Coordinator for 5 years in two hospitals in France where I have developed a special interest in communication with patients included in clinical trials mostly in phase II&III. Between these 2 experiences I worked as Clinical Research Associate for 1 year for a French Federation specializing in digestive oncology for clinical trials phase I, II and III.
Thereafter I was lucky to work in Singapore for 3 years as Project Manager in a central laboratory.
Before joining A4P as Biosample Operations Specialist in July 2022 I started living and working in Switzerland as Packaging Project Manager at Fisher Clinical Services in customer services for 2 years.
Dr Catarina Horro Pita holds a BSc in Chemistry and Environmental Chemistry and a PhD in Synthetic Organic Chemistry. After concluding her PhD at Loughborough University (UK), she began her professional career as a Synthetic Chemist, prior to moving into Analytical Chemistry and Bioanalysis. She has been working in the field of Bioanalysis for over 16 years, holding both scientific and managerial positions. During her career, she has gained significant experience in the development, validation and management of LC-MS/MS assays for the analysis of both xenobiotic compounds and small molecule biomarkers. She has been working at A4P since May 2021.
Amy studied Forensic Biology at the University of the West of England, in Bristol, and then began her career as a scientist in a biotechnology company specialising in protein conjugation. Throughout her time here, Amy worked within many of the company departments (inc. Manufacturing, RnD, Logistics), developing and improving processes and quality as the company expanded, and then spent a length of time in a Customer Service and Technical Support role, balancing her knowledge of both the technical aspects of the products and of company operations.
From here, Amy moved to a company who provided prescription data to pharmaceutical companies, to assist in market research and targeted sales strategies, before settling into the Clinical Trials industry with her role at the Clinical Reference Laboratory where she managed clinical trials from the Central Laboratory perspective. She worked on a variety of studies here, contracted either by CRO’s or pharmaceutical companies of all sizes, and across a range of indications and therapeutic areas.
Janice has completed a Masters in Applied Biosciences and has extensive experience of managing multi-disciplinary and cross-functional projects. She has multiple years' experience of managing large molecule immunoassay projects in regulated GLP/GCP, and has also worked in large molecule R&D. She has a strong ability to problem solve, with a focus on creating positive relationships. Janice currently uses her coaching and mentoring qualifications to support young scientists by participating in an annual graduate mentoring scheme.
Marleen joined A4PBio after leaving her academic employment as Teaching Fellow and Teaching Associate at the School of Pharmacy at the University of Reading. Before leaving for Academia, she worked as a Biosample Operations Associate for 1.5 years in the late phase team at Roche. There, she supported the global team on multiple early-phase studies and was also involved in creating training material and implementing/ testing internal software developments. Prior to her undergraduate studies which she supported with various research lab jobs, she worked for 4 years at the University Hospital in Rostock (Germany) performing functional diagnostics for the Cardiology ward.
Karen has worked in the biotech, Pharma and CRO industries for the past 25 years, mostly supporting biomarker analysis. During this time, she have acted as a GCP/GLP Study director on numerous preclinical and clinical studies supporting small molecule PK and biomarker analysis. This has involved oversight of LC-MS/MS and immunoassay projects, outsourcing, assay troubleshooting and interactions with various clinical teams.
Alex joined A4P in January 2020, having spent the previous 14 years working within a Contract Research Organisation. During that time, Alex worked as a Scientist, Senior Scientist and Principal Scientist in the Large Molecule Bioanalysis department. Alex has extensive experience in immunoassay method development to support PK, ADA and Biomarker assay validation and bioanalysis. Alex also has over 12 years of experience as a Regulated Project Manager (GLP/GCP) managing method validation and bioanalysis studies. As a Principal Scientist, Alex provided technical expertise to clients and the business development and operational teams. At A4P, Alex works within a team of experienced Bioanalytical Project Managers who provide scientific oversight for outsourced activities in support of Biomarker, PK and Immunogenicity programmes.
Ana joined A4P in 2022 as a Genomics project manager after working in Human Genetics for nearly 20 years. Ana started her career in science with a scientific research grant at IPATIMUP institute in Porto before moving to London and completing her PhD in Human Genetics at University College London focusing on the genetic susceptibility to gastric diseases. Ana has extensive lab experience, including postdocs at Cancer Research UK in London working on mitotic recombination in the APC region in colorectal cancer and at the University of Oxford working on the characterisation of transcription factors binding sites using High-Throughput technologies. Ana also worked as a Genetics Specialist for Coimbra Genomics, a small start-up biotechnology company focusing in healthcare. More recently, Ana was a project manager at the Oxford Genomics Centre at the University of Oxford acting as an adviser on sequencing and library preparation technologies and managing sequencing projects.
Laurie joined A4P in 2022 after spending the previous 14 years working within Contract Research Organisations. In her early career Laurie worked in sample management before moving into large molecule bioanalysis as a lab-based scientist within immunoassay and then moving into project management of GCP and GLP regulated bioanalytical studies with a particular focus on PK analysis. Laurie has worked across development, validation and early to late phase sample analysis studies. Laurie has a keen interest in quality and enjoys collaborating within project teams.
Nicola joined A4P in 2021 and her career to date spans 7 years of immunoassay development and validation in a GMP setting, 13 years of large molecule PK/PD/ADA bioanalytical regulated (GCP/GLP) project management within Contract Research Organisations and 2 years supporting the bioanalytical activities of pre-clinical and clinical studies within Pharma. Nicola has experience of management of outsourced activities in support of bioanalytical programs and offers insight from both the CRO and Sponsor perspectives. Leading teams of scientists within the CRO setting has led to the development of skills which translate well to the management of outsourced activities and the building of collaborative working relationships.
Aimee joined A4P in 2022 after spending 10 years at a contract research organisation. Starting out as a laboratory technician, Aimee has gained experience as a laboratory scientist, working on a range of immuno-assay types and instrumentation. Over the past 5 years, Aimee’s focus has been on analytical project management and oversight of PK and Biomarker bioanalytical studies from both clinical and pre-clinical trials. Leading GCP and GLP regulated studies, Aimee has supported in external audits with clients and governing bodies such as the FDA.
Tiago has been working as an Oncology Biomarker Scientist supporting A4Pbio clients in the strategy and implementation of Biomarker plans in clinical trials. I have joined from 6 years of working at Adaptimmune, a "TCR" cell therapy company, in the Target Discovery group and collaborated with translational and clinical studies in the company, helping patients get the best cutting-edge therapy against cancer. Prior to moving to the UK, I have done a PhD and MSc in Barcelona, Spain, where I mainly focused on early neurogenesis and neuroblastoma cancers. My BSc is in Biochemistry from one of the oldest universities in the world in Coimbra, Portugal, where I was born.
CheeGee is a translational medicine expert in multiple therapeutic areas and especially in oncology and neuromuscular disease. He has extensive preclinical and clinical experience from his time in pharma (GSK, Roche) and biotechs (Proteome Sciences, Global Gene Corp). CheeGee is passionate about developing biomarker-driven strategies in clinical development plans and creating fit-for-purpose biomarker assays.